CoreCivic has added up to $150 million to its existing share buyback program. The private prison operator's board approved the expanded repurchase plan last week, according to a filing with the ...

Health-care companies rose as some beaten-down stocks recouped some of their losses. UnitedHealth Group rose by more than 7%, but remain more than one-third lower for the year to date. Similarly, ...

Vertex Pharmaceuticals has authorized an additional share repurchase program of up to $4 billion. The program does not have an expiration date and can be discontinued at any time, the Boston-based ...

Shares of Monolithic Power Systems Inc. MPWR shed 1.82% to $702.39 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.09% to ...

Verra Mobility said its board authorized a share-repurchase program of up to $100 million. The transportation-technology company said the program would run until Nov. 13, 2026. Repurchases may be made ...

This was the stock's fourth consecutive day of losses.

Fitness Champs has withdrawn the initial public offering it filed in September. The Singapore sports-education provider on Monday asked the Securities and Exchange Commission to retract the filing, ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Talos Energy said it named Gregory Babcock, the company's VP and chief accounting officer, as interim chief financial officer, effective June 28. Babcock will succeed Sergio Maiworm, who is leaving to ...

Shares of Paychex Inc. PAYX rallied 1.42% to $158.19 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.09% to 5,963.60 and the ...

Crispr Therapeutics said it is partnering with Sirius Therapeutics to develop and commercialize SRSD107, a small interfering RNA therapy to treat thromboembolic disorders. Under the agreement, Crispr ...